[1] |
Zhang SW, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2015[J]. J Natl Cancer Cent, 2021, 1(1): 2-11. DOI:10.1016/j.jncc.2020.12.001 |
|
[2] |
Ferlay J, Ervik M, Lam F, et al.Global cancer observatory:cancer today.Lyon, France:international agency for research on cancer[EB/OL].[2021-03-31]. https://gco.iarc.fr/today.
|
|
[3] |
石菊芳, 张玥, 曲春枫, 等. 以伤残调整生命年为指标的中国人群癌症疾病负担现状[J]. 中华预防医学杂志, 2015, 49(4): 365-369. Shi JF, Zhang Y, Qu CF, et al. Burden of cancer in China:data on disability-adjusted life years[J]. Chin J Prev Med, 2015, 49(4): 365-369. DOI:10.3760/cma.j.issn.0253-9624.2015.04.019 |
|
[4] |
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222. DOI:10.1016/S0140-6736(20)30925-9 |
|
[5] |
Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. DOI:10.1016/S0140-6736(19)30427-1 |
|
[6] |
曹梦迪, 王红, 石菊芳, 等. 中国人群肝癌疾病负担:多数据源证据更新整合分析[J]. 中华流行病学杂志, 2020, 41(11): 1848-1858. Cao MD, Wang H, Shi JF, et al. Disease burden of liver cancer in China:an updated and integrated analysis on multi-data source evidence[J]. Chin J Epidemiol, 2020, 41(11): 1848-1858. DOI:10.3760/cma.j.cn112338-20200306-00271 |
|
[7] |
王红, 曹梦迪, 刘成成, 等. 中国人群结直肠癌疾病负担:近年是否有变?[J]. 中华流行病学杂志, 2020, 41(10): 1633-1642. Wang H, Cao MD, Liu CC, et al. Disease burden of colorectal cancer in China:any changes in recent years?[J]. Chin J Epidemiol, 2020, 41(10): 1633-1642. DOI:10.3760/cma.j.cn112338-20200306-00273 |
|
[8] |
王乐, 张玥, 石菊芳, 等. 中国女性乳腺癌疾病负担分析[J]. 中华流行病学杂志, 2016, 37(7): 970-976. Wang L, Zhang Y, Shi JF, et al. Disease burden of famale breast cancer in China[J]. Chin J Epidemiol, 2016, 37(7): 970-976. DOI:10.3760/cma.j.issn.0254-6450.2016.07.013 |
|
[9] | |
|
[10] | |
|
[11] | |
|
[12] |
赫捷, 陈万青, 李霓, 等. 中国女性乳腺癌筛查与早诊早治指南(2021, 北京)[J]. 中国肿瘤, 2021, 30(3): 161-191. He J, Chen WQ, Li N, et al. China guideline for the screening and early detection of female breast cancer (2021, Beijing)[J]. China Cancer, 2021, 30(3): 161-191. DOI:10.11735/j.issn.1004-0242.2021.03.A001 |
|
[13] |
Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England:past and future[J]. J Med Screen, 2006, 13(2): 59-61. DOI:10.1258/096914106777589678 |
|
[14] | |
|
[15] |
Nickson C, Velentzis LS, Brennan P, et al. Improving breast cancer screening in Australia:a public health perspective[J]. Public Health Res Pract, 2019, 29(2): e2921911. DOI:10.17061/phrp2921911 |
|
[16] |
Goto R, Hamashima C, Mun S, et al. Why screening rates vary between Korea and Japan-differences between two national healthcare systems[J]. Asian Pac J Cancer Prev, 2015, 16(2): 395-400. DOI:10.7314/apjcp.2015.16.2.395 |
|
[17] |
Chen WQ, Xia CF, Zheng RS, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China:a comparative risk assessment[J]. Lancet Glob Health, 2019, 7(2): e257-269. DOI:10.1016/S2214-109X(18)30488-1 |
|
[18] |
国家卫生计生委.中国居民营养与慢性病状况报告-2015年[M].北京:人民卫生出版社, 2015. State Health and Family Planning Commission of the People's Republic of China.The nutrition and health status of the Chinese people national report (2015)[M].Beijing:People's Medical Publishing House, 2015.
|
|
[19] |
Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249. DOI:10.1016/S0140-6736(20)30752-2 |
|
[20] |
孙可欣, 郑荣寿, 顾秀瑛, 等. 2000-2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析[J]. 中华预防医学杂志, 2018, 52(6): 567-572. Sun KX, Zheng RS, Gu XY, et al. Incidence trend and change in the age distribution of female breast cancer in cancer registration areas of China from 2000 to 2014[J]. Chin J Prev Med, 2018, 52(6): 567-572. DOI:10.3760/cma.j.issn.0253-9624.2018.06.003 |
|
[21] |
Zeng HM, Chen WQ, Zheng RS, et al. Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555-567. DOI:10.1016/S2214-109X(18)30127-X |
|
[22] |
Dibden A, Offman J, Duffy SW, et al. Worldwide review and Meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality[J]. Cancers, 2020, 12(4): 976. DOI:10.3390/cancers12040976 |
|
[23] |
Sauvaget C, Nishino Y, Konno R, et al. Challenges in breast and cervical cancer control in Japan[J]. Lancet Oncol, 2016, 17(7): e305-312. DOI:10.1016/S1470-2045(16)30121-8 |
|
[24] | |
|
[25] |
代敏, 石菊芳, 李霓. 中国城市癌症早诊早治项目设计及预期目标[J]. 中华预防医学杂志, 2013, 47(2): 179-182. Dai M, Shi JF, Li N. The design and expectation of cancer screening program in urban China[J]. Chin J Prev Med, 2013, 47(2): 179-182. DOI:10.3760/cma.j.issn.0253-9624.2013.02.018 |
|
[26] |
龚政.2015-2017年新疆生产建设兵团恶性肿瘤疾病负担研究[D].乌鲁木齐:新疆医科大学, 2019. Gong Z.Disease burden of malignant neoplasms in Xinjiang production and construction crops from 2015 to 2017[D].Urumqi:Xinjiang Medical University, 2019.
|
|
[27] |
杨丽, 陈娜萦, 黄开勇, 等. 2008-2013年广西居民恶性肿瘤疾病负担的研究[J]. 中华疾病控制杂志, 2016, 20(5): 500-503, 507. Yang L, Chen NY, Huang KY, et al. Burden of cancer in Guangxi Zhuang Autonomous Region 2008-2013[J]. Chin J Dis Control Prev, 2016, 20(5): 500-503, 507. DOI:10.16462/j.cnki.zhjbkz.2016.05.017 |
|
[28] |
孙建东.山东省恶性肿瘤疾病负担研究[D].济南:山东大学, 2008. Sun JD.Estimation of the burden of malignant neoplasms in Shandong province[D].Ji'nan:Shandong University, 2008.
|
|
[29] |
Chie WC, Chen SY, Chang KJ. Disability-adjusted life years for breast cancer patients in Taiwan[J]. J Formos Med Assoc, 2001, 100(1): 20-25. |
|